Abstract:Yanzhi Feng, 1– 4, &ast Litao Liang, 1– 4, &ast Wenbo Jia, 1– 4 Jinyi Wang, 1– 4 Chao Xu, 1– 4 Deming Zhu, 1– 4 Bin Xu, 1– 4 Wenhu Zhao, 1– 4 Xiangyu Ling, 1– 4 Yongping Zhou, 5 Lianbao Kong, 1– 4, &ast Wenzhou Ding 1– 4, &ast 1 Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 2 Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, National Health Commission Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu, People's Republic of China; 3 Jiangsu Provincial Medical Innovation Center, Nanjing, Jiangsu, People's Republic of China; 4 Jiangsu Provincial Medical Key Laboratory, Nanjing, Jiangsu, People's Republic of China; 5 Jiangnan University Medical Center, JUMC, Department of Hepatobiliary, Wuxi, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenzhou Ding; Lianbao Kong, Hepatobiliary Centre, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China, Email ; Background: Circular RNAs (circRNAs) have been shown to play a crucial role in the initiation and development of Hepatocellular carcinoma (HCC). However, the mechanism and function of circ_0007386 in HCC are still unknown. Methods: Circ_0007386 expression level in HCC tissues, and HCC cell lines was further analyzed by qRT-PCR. Agarose gel electrophoresis and Sanger sequencing were used to figure out the structure of circ_0007386. The involvement of circ_0007386 in HCC development was evaluated by experimental investigations conducted in both laboratory settings (in vitro) and living organisms (in vivo). RNA immunoprecipitation, Western blotting, luciferase reporter assay and fluorescence in situ hybridization (FISH) were applied for finding out the interaction among circ_0007386, miR-507 and CCNT2. To assess the connection between circ_0007386 and lenvatinib resistance, lenvatinib-resistant HCC cell lines were employed. Results: The expression of circ_0007386 was found to increase in HCC tissues, and it was observed to be associated with a worse prognosis. Overexpression of circ_0007386 stimulated HCC cells proliferation, invasion, migration and the epithelial–mesenchymal transition (EMT) while silencing of circ_0007386 resulted in the opposite effect. Mechanistic investigations revealed that circ_0007386 acted as a competing endogenous RNA of miR-507 to prevent CCNT2 downregulation. Downregulating miR-507 or overexpressing CCNT2 could reverse phenotypic alterations that originated from inhibiting of circ_0007386. Importantly, circ_0007386 determines the resistance of hepatoma cells to lenvatinib treatment. Conclusion: Circ_0007386 advanced HCC progression and lenvatinib resistance through the miR-507/ CCNT2 axis. Meanwhile, circ_0007386 served as a potential biomarker and therapeutic target in HCC patients. Keywords: hepatocellular carcinoma, circ_0007386, miR-507, CCNT2, Lenvatinib Graphical Hepatocellular cancer (HCC) is the fourth leading cause of cancer death worldwide and the second largest cause of impaired cancer life expectancy worldwide, which emphasizes the significant disease burden of liver cancer. 1 The treatment of HCC is a full-spectrum therapy modality based on aggressive resection, whereas there are no effective molecular therapeutic targets. Despite various attempts to improve treatment choices, HCC still has a dismal prognosis. 2 Therefore, research on the genetic and molecular basis of HCC development is critical. Circular RNAs (circRNAs), noncoding RNAs (ncRNAs), are regarded as modulators of gene expression, m6A modification and RNA binding proteins. Furthermore, current studies have demonstrated that circRNAs can behave as molecular sponges for miRNA regulation and interact with RNA-binding proteins to modulate transcriptional processes. 3–5 An increasing number of circRNAs have been linked to tumor growth, suggesting that they may play a crucial role in the pathogenesis of many different tumor types. 6–8 The above findings suggest that circRNAs hold significant research potential. Nevertheless, a considerable number of circRNAs remain to be identified and investigated. Studies have demonstrated the significance of circRNAs produced from CRIM1 in a variety of carcinomas, including bladder cancer, ovarian cancer, and nasopharyngeal carcinoma. 9–11 However, the function of -Abstract Truncated-

CircCCNB1 Silencing Acting As a Mir-106B-5p Sponge Inhibited GPM6A Expression to Promote HCC Progression by Enhancing DYNC1I1 Expression and Activating the AKT/ERK Signaling Pathway

Integrated Multiomics Reveals Silencing of Has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis

CircCTNNA1 Acts As a Cerna for Mir-363-3p to Facilitate the Progression of Colorectal Cancer by Promoting CXCL5 Expression

Transcriptome Sequencing of Hepatocellular Carcinoma Uncovers Multiple Types of Dysregulated Ncrnas

Silencing of Hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation of Microrna-214-3p/ezh2 Axis

circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346

Circ_0007385 Served As Competing Endogenous RNA for Mir‐519d‐3p to Suppress Malignant Behaviors and Cisplatin Resistance of Non‐small Cell Lung Cancer Cells

CircRNA-104718 Acts As Competing Endogenous RNA and Promotes Hepatocellular Carcinoma Progression Through Microrna-218-5p/txndc5 Signaling Pathway

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma

Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25

Circ_0084615 promotes epithelial‐mesenchymal transition‐mediated tumor progression in hepatocellular carcinoma

Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway

Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation

CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma

Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis

Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e

CircCRIM1 Promotes Hepatocellular Carcinoma Proliferation and Angiogenesis by Sponging miR-378a-3p and Regulating SKP2 Expression

Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR‐496/programmed cell death ligand 1 axis in an m6A‐dependent manner

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis

Hsa_circ_103973 Acts As a Sponge of Mir-335 to Promote Cervical Cancer Progression